Antibiotic susceptibility profile of bacterial isolates from febrile children under 5 years of age in Nanoro, Burkina Faso.


Journal

Tropical medicine & international health : TM & IH
ISSN: 1365-3156
Titre abrégé: Trop Med Int Health
Pays: England
ID NLM: 9610576

Informations de publication

Date de publication:
10 2021
Historique:
pubmed: 30 6 2021
medline: 28 12 2021
entrez: 29 6 2021
Statut: ppublish

Résumé

Antibiotics efficacy is severely threatened due to emerging resistance worldwide, but there is a paucity of antibiotics efficacy data for the West African region in general. Therefore, this study aimed to determine the antibiotic susceptibility profile of bacterial isolated from febrile children under 5 years of age in Nanoro (Burkina Faso). Blood, stool and urine samples were collected from 1099 febrile children attending peripheral health facilities and the referral hospital in Nanoro Health district. Bacterial isolates from these samples were assessed for their susceptibility against commonly used antibiotics by Kirby-Bauer method. In total, 141 bacterial isolates were recovered from 127 febrile children of which 65 from blood, 65 from stool and 11 from urine. Salmonella isolates were most frequently isolated and found to be highly resistant to ampicillin (70%; 56/80) and trimethoprim-sulphamethoxazole (65%; 52/80). Escherichia coli isolates showed a high resistance rate to trimethoprim-sulphamethoxazole (100%), ampicillin (100%), ciprofloxacin (71.4%; 10/14), amoxicillin-clavulanate (64.3%; 9/14), ceftriaxone (64.3%; 9/14) and gentamycin (50%; 7/14). Moreover, half of the E. coli isolates produced ß-lactamase suggesting multi-drug resistance against β-lactam as well as non-β-lactam antibiotics. Multi-drug resistance was observed in 54.6% (59/108) of the isolates, mainly Gram-negative bacteria. This study showed high resistance rates to common antibiotics used to treat bacterial infections in Nanoro. The work prompts the need to expand antibiotic resistance surveillance studies in Burkina Faso.

Identifiants

pubmed: 34185935
doi: 10.1111/tmi.13644
pmc: PMC8596758
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1220-1230

Informations de copyright

© 2021 The Authors Tropical Medicine & International Health Published by John Wiley & Sons Ltd.

Références

Clin Infect Dis. 2006 Jan 15;42 Suppl 2:S82-9
pubmed: 16355321
J Pediatr Pueric. 2010 May;23(2):84-95
pubmed: 32288393
Can J Microbiol. 2014 Mar;60(3):147-54
pubmed: 24588388
S Afr Med J. 2015 Apr 06;105(5):325
pubmed: 26242647
J Infect Dev Ctries. 2014 Feb 13;8(2):129-36
pubmed: 24518621
Ann N Y Acad Sci. 2014 Sep;1323:43-55
pubmed: 24628272
Antimicrob Agents Chemother. 2004 Jan;48(1):1-14
pubmed: 14693512
Trop Med Int Health. 2012 Feb;17(2):211-22
pubmed: 21999394
Korean J Intern Med. 2012 Jun;27(2):128-42
pubmed: 22707882
Saudi J Biol Sci. 2015 Jan;22(1):90-101
pubmed: 25561890
Pan Afr Med J. 2018 Jan 17;29:42
pubmed: 29875924
Int J Antimicrob Agents. 2017 Nov;50(5):629-639
pubmed: 28705671
Int J Epidemiol. 2012 Oct;41(5):1293-301
pubmed: 23045201
J Clin Microbiol. 2010 Jun;48(6):2171-6
pubmed: 20392916
PLoS One. 2016 Nov 10;11(11):e0166384
pubmed: 27832151
Pak J Biol Sci. 2009 May 1;12(9):712-6
pubmed: 19634476
Antimicrob Resist Infect Control. 2017 Jan 11;6:9
pubmed: 28096977
BMC Infect Dis. 2016 Jul 11;16:326
pubmed: 27400864
Lancet Infect Dis. 2018 Feb;18(2):e33-e44
pubmed: 29033034
Curr Opin Pharmacol. 2014 Oct;18:56-60
pubmed: 25254623
J Infect. 2018 Mar;76(3):270-279
pubmed: 29253559
Cochrane Database Syst Rev. 2011 Oct 05;(10):CD004530
pubmed: 21975746
Ann Clin Microbiol Antimicrob. 2019 Jan 28;18(1):5
pubmed: 30691506
Lancet Infect Dis. 2019 Jan;19(1):56-66
pubmed: 30409683
Virulence. 2013 Feb 15;4(2):185-91
pubmed: 23302792
Diagnostics (Basel). 2019 May 03;9(2):
pubmed: 31058811
J Clin Microbiol. 2015 Jan;53(1):262-72
pubmed: 25392358
Trop Med Int Health. 2021 Oct;26(10):1220-1230
pubmed: 34185935
PLoS One. 2014 Feb 14;9(2):e89103
pubmed: 24551225
Eur J Microbiol Immunol (Bp). 2017 Sep 11;7(3):168-175
pubmed: 29034106

Auteurs

Massa Dit Achille Bonko (MDA)

Institut de Recherche en Science de la Santé - Direction régionale du Centre-Ouest/Unité de Recherche Clinique de Nanoro, Nanoro, Burkina Faso.
Department of Medical Microbiology, Experimental Parasitology Unit, Amsterdam University Medical Centers, Academic Medical Center at the University of Amsterdam, Amsterdam, The Netherlands.

Marc Christian Tahita (MC)

Institut de Recherche en Science de la Santé - Direction régionale du Centre-Ouest/Unité de Recherche Clinique de Nanoro, Nanoro, Burkina Faso.

Francois Kiemde (F)

Institut de Recherche en Science de la Santé - Direction régionale du Centre-Ouest/Unité de Recherche Clinique de Nanoro, Nanoro, Burkina Faso.
Department of Medical Microbiology, Experimental Parasitology Unit, Amsterdam University Medical Centers, Academic Medical Center at the University of Amsterdam, Amsterdam, The Netherlands.

Palpouguini Lompo (P)

Institut de Recherche en Science de la Santé - Direction régionale du Centre-Ouest/Unité de Recherche Clinique de Nanoro, Nanoro, Burkina Faso.

Sibidou Yougbaré (S)

Institut de Recherche en Science de la Santé - Direction régionale du Centre-Ouest/Unité de Recherche Clinique de Nanoro, Nanoro, Burkina Faso.

Athanase M Some (AM)

Institut de Recherche en Science de la Santé - Direction régionale du Centre-Ouest/Unité de Recherche Clinique de Nanoro, Nanoro, Burkina Faso.

Halidou Tinto (H)

Institut de Recherche en Science de la Santé - Direction régionale du Centre-Ouest/Unité de Recherche Clinique de Nanoro, Nanoro, Burkina Faso.

Petra F Mens (PF)

Department of Medical Microbiology, Experimental Parasitology Unit, Amsterdam University Medical Centers, Academic Medical Center at the University of Amsterdam, Amsterdam, The Netherlands.

Sandra Menting (S)

Department of Medical Microbiology, Experimental Parasitology Unit, Amsterdam University Medical Centers, Academic Medical Center at the University of Amsterdam, Amsterdam, The Netherlands.

Henk D F H Schallig (HDFH)

Department of Medical Microbiology, Experimental Parasitology Unit, Amsterdam University Medical Centers, Academic Medical Center at the University of Amsterdam, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH